Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Refractory nephrotic syndrome].

Takao Saito1

  • 1Division of Nephrology and Rheumatology, Department of Internal Medicine, Fukuoka University School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|October 27, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient with Secondary Amyloidosis Due to Crohn's Disease on Hemodialysis Effectively Treated with Ferric Carboxymaltose Injections: A Case Report and Literature Review.

Diseases (Basel, Switzerland)·2025
Same author

Exploring the association of natriuretic peptides with QTc interval in hemodialysis patients.

Renal failure·2025
Same author

Impact of Apolipoprotein E Variants: A Review of Naturally Occurring Variants and Clinical Features.

Journal of atherosclerosis and thrombosis·2025
Same author

Lipoprotein glomerulopathy with a novel apolipoprotein E variant, APOE Kanto (Asp 151dup).

CEN case reports·2024
Same author

Lipoprotein glomerulopathy with markedly increased arterial stiffness successfully treated with a combination of fenofibrate and losartan: a case report.

BMC nephrology·2024
Same author

Apolipoprotein E-associated Lipoprotein Glomerulo-tubulopathy.

Internal medicine (Tokyo, Japan)·2023
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

Refractory nephrotic syndrome, resistant to standard treatments, affects 10-12% of idiopathic cases in Japan. Persistent proteinuria is a key risk factor for end-stage renal disease progression.

Area of Science:

  • Nephrology
  • Immunosuppression Therapy
  • Renal Pathology

Context:

  • Refractory nephrotic syndrome is defined in Japan as resistance to immunosuppressive therapy for over six months.
  • Idiopathic nephrotic syndrome cases resistant to treatment account for 10-12% of all idiopathic cases.
  • Adults with refractory nephrotic syndrome most commonly have idiopathic membranous nephropathy (40%) or focal segmental glomerulosclerosis (20%).

Purpose:

  • To define refractory nephrotic syndrome in the Japanese context.
  • To identify the prevalence and common causes of refractory nephrotic syndrome in adults.
  • To highlight the significance of proteinuria in the progression of renal disease.

Summary:

  • Refractory nephrotic syndrome is a significant subset of idiopathic nephrotic syndrome in Japan.

Related Experiment Videos

  • Idiopathic membranous nephropathy and focal segmental glomerulosclerosis are the leading causes in adults.
  • Achieving reduced proteinuria (<1 g/day) is crucial for preventing end-stage renal disease (ESRD).

    • Impact:

    • Persistent proteinuria is a critical marker of glomerular damage and a risk factor for tubulointerstitial lesions.
    • Effective management of proteinuria is essential to slow or halt the progression to ESRD.
    • Understanding refractory nephrotic syndrome aids in developing targeted therapeutic strategies for kidney disease patients.